CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Tumor growth inhibition of MDA-MB–231 estrogen independent human breast cancer by treatment with antagonist of LHRH Cetrorelix®
DOI 10.1055/s-0028-1088822
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Seitz, AV Schally, F Koester, A Papadia, O Ortmann, S Buchholz
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: The efficacy of endocrine therapy with agonists of luteinizing hormone releasing hormone (LHRH) in premenopausal women with estrogen dependent breast cancers is well established. The expression of LHRH and its receptor as part of an autocrine, paracrine regulatory mechanism of cell proliferation has been shown in various cancers, including breast cancer. In this study we investigated the direct effect…
Zitieren
Zitierempfehlung
S Seitz, AV Schally, F Koester, A Papadia, O Ortmann, S Buchholz (2008) Tumor growth inhibition of MDA-MB–231 estrogen independent human breast cancer by treatment with antagonist of LHRH Cetrorelix®. Geburtshilfe und Frauenheilkunde (09). https://doi.org/10.1055/s-0028-1088822
Mit CareLit weiterarbeiten